• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

T8S:GR

22.672 EUR 0.608 2.61%

As of 02:03:33 ET on 08/20/2014.

Snapshot for TESARO Inc (T8S)

Open: 22.672 Day's Range: 22.672 - 22.672 Volume: 0
Previous Close: 23.280 52wk Range: 16.196 - 34.040 1-Yr Rtn: -2.17%

Stock Chart for T8S

No chart data available.
  • T8S:GR 22.672
  • 1D
  • 1M
  • 1Y
23.280
Interactive T8S Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for T8S

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -4.5070
Est. PEG Ratio -
Market Cap (M EUR) 817.17
Shares Outstanding (M) 36.04
30 Day Average Volume 13
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for T8S

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for T8S

Tesaro, Inc. develops and commercializes cancer therapeutics and supportive care products. The Company offers receptor antagonist for the prevention of chemotherapy induced nausea and vomiting. Tesaro operates in the United States.

David M Mott "Dave"ChairmanLeon O Moulder Jr "Lonnie"CEO/Co-Founder
Mary Lynne HedleyPres/COO/Chief Scientific OfcrTimothy Pearson "Tim"Exec VP/CFO
More Company Profile & Key Executives for T8S

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil